When it comes to health insurance, the existence of moral hazard is a more matter-of-fact issue: When people get health insurance, they use more medical care, as shown by research including a recent randomized study on the impact of Medicaid, which MIT economist Amy Finkelstein helped lead.
Such evidence helps explain why insurers and policymakers looking to reduce overall costs have become increasingly attracted to the concept of "consumer-directed medical care," in which consumers pay for a larger share of medical expenses, sometimes in the form of high-deductible insurance plans. If people have to bear greater initial costs (the deductible is the amount consumers must pay before coverage kicks in), they may be less likely to seek insured medical care for seemingly marginal health issues.
But a new paper co-authored by Finkelstein suggests that forecasting the likely spending reduction associated with high deductibles requires a fine-grained approach, to account for the differing ways consumers respond to incentives in the health-care market. The research indicates that consumers select insurance plans based not only on their overall wellness level — with people in worse health opting for more robust coverage — but also on their own anticipated response to having insurance.
By scrutinizing a large data set based on choices made by employees of Alcoa, Inc., the researchers found that consumers selecting a new insurance policy who expect to reduce their use of medical care by a lot if they have to pick up additional costs shy away from high-deductible plans; by contrast, the people who opt for high-deductible plans are the ones who expect to change their health-care use the least.
Thus insurers, or at least those who expect that offering more high-deductible plans will lower their expenses, may experience smaller spending changes than they might expect if a random group of people were assigned to such plans.
"What we [find] is that if you base your forecasts on random assignment, you would substantially overestimate the spending reduction you can get by introducing high-deductible plans," says Finkelstein, the Ford Professor of Economics at MIT. "The people who select these plans aren't randomly drawn from the population — they tend to be people who have a lower behavioral response to the [insurance] contract."
But how much more care do people in the second group seek? The paper, "Selection on Moral Hazard in Health Insurance," published this month in the American Economic Review, answers that question by scrutinizing health-plan choices made between 2003 and 2006 by more than 4,000 employees at Alcoa, the global aluminum producer. The researchers were able to assess the overall health status of individuals, the health-plan choices employees made when switching coverage, and subsequent medical claims. The varying Alcoa plans offered different deductibles, but used the same network of health-care providers, meaning consumer choices were heavily based on financial concerns.
By analyzing the data this way, the researchers were able to identify the links between insurance-plan choices, overall health status, and changes in behavior — or "moral hazard" — as measured by increased claims. In quantitative terms, their bottom-line finding is that these two factors are equally significant: "Selection on moral hazard is roughly as important as selection on health risk," the paper notes.
"There may be heterogeneity, and people may differ in how much more they spend when they get health insurance," Finkelstein notes.
That finding could influence the way insurance firms and policymakers structure plan choices and estimate overall costs. "In a world in which people chose health plans based on not just how sick they think they are, but also on how much they think they're going to increase their medical care use when the care is subsidized," Finkelstein says, it could significantly affect how much health-care spending would be reduced through mechanisms such as high-deductible plans.
In addition to Finkelstein, the co-authors of the paper are Mark Cullen, a professor in Stanford University's School of Medicine; Liran Einav, an economist at Stanford; Stephen Ryan, an economist at the University of Texas at Austin; and Paul Schrimpf, an economist at the University of British Columbia. Since 1997, Cullen has worked in coordination with Alcoa to study employee health issues.Hard evidence — but more would be useful
Written by: Peter Dizikes, MIT News Office
Sarah McDonnell | EurekAlert!
Diagnoses: When Are Several Opinions Better Than One?
19.07.2016 | Max-Planck-Institut für Bildungsforschung
High in calories and low in nutrients when adolescents share pictures of food online
07.04.2016 | University of Gothenburg
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences